Literature DB >> 11835456

Botulinum toxin and short-term electrical stimulation in the treatment of equinus in cerebral palsy.

C Detrembleur1, T M Lejeune, A Renders, P Y K Van Den Bergh.   

Abstract

Intramuscular botulinum toxin type A (BT-A) has been shown to reduce spasticity and to improve gait in children with cerebral palsy. To determine whether the efficacy of BT-A may be enhanced by electrical stimulation, as suggested in focal dystonia or in adult spastic patients, 12 children with dynamic foot equinus deformity were randomly assigned to two groups in a blinded, clinically controlled trial. Intramuscular BT-A into calf muscles was followed by adjuvant electrical stimulation in Group A (n = 6) but not in Group B (n = 6). Clinical assessment and instrumented gait analysis were performed before and 1, 3, and 6 months after treatment. The combined treatment of BT-A and electrical stimulation was not superior to BT-A alone. For all patients, improvement of the clinical and gait variables occurred at 1 and 3 months after BT-A injection. Copyright 2001 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11835456     DOI: 10.1002/mds.1282

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  11 in total

Review 1.  Botulinum toxin treatment of children with cerebral palsy - a short review of different injection techniques.

Authors:  A S Schroeder; S Berweck; S H Lee; F Heinen
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

2.  Calculation of the external work done during walking in very young children.

Authors:  Benedicte Schepens; Christine Detrembleur
Journal:  Eur J Appl Physiol       Date:  2009-07-26       Impact factor: 3.078

Review 3.  Botulinum toxin in children with cerebral palsy.

Authors:  Pratibha Singhi; Munni Ray
Journal:  Indian J Pediatr       Date:  2004-12       Impact factor: 1.967

Review 4.  Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.

Authors:  Marissa Barlaan Lukban; Raymond L Rosales; Dirk Dressler
Journal:  J Neural Transm (Vienna)       Date:  2009-01-14       Impact factor: 3.575

5.  Is electrical stimulation beneficial for improving the paralytic effect of botulinum toxin type A in children with spastic diplegic cerebral palsy?

Authors:  Dong-wook Rha; Eun Joo Yang; Ho Ik Chung; Hyoung Bin Kim; Chang-il Park; Eun Sook Park
Journal:  Yonsei Med J       Date:  2008-08-30       Impact factor: 2.759

6.  To Evaluate the Effectiveness of TBTS - A Novel Device to do Self-Stretching of Gastroc-Soleus Muscle in Patients with Equinus Deformity.

Authors:  Tufail Muzaffar; Abdul Hamid Rather; Kaleem Ul Haque; Sheikh Javeed Ahmad
Journal:  J Clin Diagn Res       Date:  2017-06-01

7.  Effectiveness of electrical stimulation after administration of botulinum toxin in children with spastic diplegic cerebral palsy: A prospective, randomized clinical study.

Authors:  Pembe Yiğitoğlu; Erkan Kozanoğlu
Journal:  Turk J Phys Med Rehabil       Date:  2019-02-04

Review 8.  Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy.

Authors:  Francesco C Blumetti; João Carlos Belloti; Marcel Js Tamaoki; José A Pinto
Journal:  Cochrane Database Syst Rev       Date:  2019-10-08

Review 9.  Electrical Stimulation of Injected Muscles to Boost Botulinum Toxin Effect on Spasticity: Rationale, Systematic Review and State of the Art.

Authors:  Alessandro Picelli; Mirko Filippetti; Giorgio Sandrini; Cristina Tassorelli; Roberto De Icco; Nicola Smania; Stefano Tamburin
Journal:  Toxins (Basel)       Date:  2021-04-23       Impact factor: 4.546

10.  IGF-1 antibody prolongs the effective duration time of botulinum toxin in decreasing muscle strength.

Authors:  Lingjing Jin; Lizhen Pan; Wuchao Liu; Yan Guo; Yuguo Zheng; Qiang Guan; Zhiyu Nie
Journal:  Int J Mol Sci       Date:  2013-04-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.